Captrust Financial Advisors Celcuity Inc. Transaction History

Captrust Financial Advisors

$46.7 Billion
Q3 2025

A detailed history of Captrust Financial Advisors transactions in Celcuity Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 67,535 shares of CELC stock, worth $6.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

67,535

Previous 570,441 88.16%

Holding current value

$6.24 Million

Previous $7.62 Million 56.41%

% of portfolio

0.01%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 19, 2025	SELL	$12.58 - $62.68 $6.33 Million - $31.5 Million	-502,906 Reduced 88.16%	67,535 $3.32 Million
Q2 2025 Aug 14, 2025	BUY	$8.21 - $13.35 $105,399 - $171,387	12,838 Added 2.3%	570,441 $7.62 Million
Q1 2025 May 14, 2025	BUY	$8.62 - $13.62 $771,550 - $1.22 Million	89,507 Added 19.12%	557,603 $5.64 Million
Q4 2024 Feb 14, 2025	BUY	$12.0 - $16.35 $75,624 - $103,037	6,302 Added 1.36%	468,096 $6.13 Million
Q3 2024 Nov 14, 2024	SELL	$13.98 - $19.15 $503 - $689	-36 Reduced 0.01%	461,794 $6.89 Million

Q2 2024 Aug 14, 2024	SELL	$14.1 - $20.78 $76,351 - $112,523	-5,415 Reduced 1.16%	461,830 $7.56 Million
Q1 2024 May 15, 2024	SELL	$13.74 - $21.6 $1.07 Million - $1.68 Million	-77,590 Reduced 14.24%	467,245 $10.1 Million
Q4 2023 Feb 14, 2024	SELL	$8.7 - $15.02 $70,148 - $121,106	-8,063 Reduced 1.46%	544,835 $7.94 Million
Q3 2023 Nov 14, 2023	SELL	$8.96 - $10.75 $49,880 - $59,845	-5,567 Reduced 1.0%	552,898 $5.05 Million
Q2 2023 Aug 14, 2023	SELL	$9.39 - $12.18 $109,675 - $142,262	-11,680 Reduced 2.05%	558,465 $6.13 Million
Q1 2023 May 15, 2023	SELL	$9.4 - $12.82 $571,200 - $779,020	-60,766 Reduced 9.63%	570,145 $5.84 Million
Q4 2022 Feb 15, 2023	SELL	$7.55 - $14.01 $17,198 - $31,914	-2,278 Reduced 0.36%	630,911 $8.84 Million
Q3 2022 Nov 16, 2022	BUY	$8.0 - $10.64 $5.03 Million - $6.68 Million	628,189 Added 12563.78%	633,189 $6.36 Million
Q2 2020 Aug 14, 2020	BUY	$4.42 - $11.04 $22,100 - $55,199	5,000 New	5,000 $35,000
Q4 2019 Feb 14, 2020	SELL	$9.47 - $16.71 $33,618 - $59,320	-3,550 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$15.74 - $23.65 $8,657 - $13,007	550 Added 18.33%	3,550 $60,000
Q2 2019 Aug 13, 2019	BUY	$19.88 - $25.0 $44,730 - $56,250	2,250 Added 300.0%	3,000 $75,000
Q1 2018 May 15, 2018	BUY	$13.55 - $21.3 $3,387 - $5,325	250 Added 50.0%	750 $12,000
Q3 2017 Feb 16, 2018	BUY	$11.94 - $14.29 $5,970 - $7,145	500	500 $8,000

Others Institutions Holding CELC

# of Institutions

188

Shares Held

38.2M

Call Options Held

574K

Put Options Held

205K

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $1.38B
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Celcuity Inc. Transaction History